17-carbamoyloxy cortisol derivatives as selective glucocorticoid receptor modulators

Details for Australian Patent Application No. 2004207482 (hide)

International Classifications

Event Publications

21 July 2005 Amendment Made

The nature of the amendment is: Amend the name of the applicant from Merck & Co. Inc. to Merck & Co., Inc.

21 July 2005 PCT application entered the National Phase

PCT publication WO2004/066920 Priority application(s): WO2004/066920

8 October 2009 Application Accepted

Published as AU-B-2004207482

28 January 2010 Alteration of Name

The name of the applicant has been altered to Merck Sharp & Dohme Corp.

4 February 2010 Standard Patent Sealed

9 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.